Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Help & FAQ
Dansk
English
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
Search by expertise, name or affiliation
Beta-adrenergic blockade in cirrhosis - harmful or helpful?
Søren Møller
,
Karen V Danielsen
,
Puria Nabilou
,
Nina Kimer
,
Flemming Bendtsen
Gastrounit, Medical Division
Gastrounit
Centre for Functional and Diagnostic Imaging and research
Clinical Physiology and Nuclear Medicine, Department of
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Beta-adrenergic blockade in cirrhosis - harmful or helpful?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Beta-blockers
100%
Cirrhosis
100%
Portal Hypertension
100%
β-adrenergic Blockade
100%
Renal Disease
50%
Ascites
50%
Varices
50%
Pathophysiology
25%
Disease Course
25%
Treatment Effect
25%
Encephalopathy
25%
Disease Stage
25%
Major Complications
25%
Cardiac Dysfunction
25%
Primary Prophylaxis
25%
Direct Measurement
25%
Secondary Prophylaxis
25%
Adverse Reactions
25%
Carvedilol
25%
Pharmacological Effects
25%
Advanced Cirrhosis
25%
Bleeding from Esophageal Varices
25%
Portal Pressure
25%
Variceal Bleeding
25%
Decompensated Cirrhosis
25%
Personalized Treatment
25%
Nonselective β-blockers
25%
Large Varices
25%
Clinically Significant Portal Hypertension
25%
Esophageal Bleeding
25%
Medicine and Dentistry
Liver Cirrhosis
100%
Portal Hypertension
100%
Beta Adrenergic Receptor Blocking Agent
100%
Beta Adrenergic Receptor Blocking
100%
Varices
60%
Bleeding
40%
Ascites
40%
Pathophysiology
20%
Disease Course
20%
Disease
20%
Adverse Event
20%
Brain Disease
20%
Carvedilol
20%
Esophageal Varices
20%
Portal Venous Pressure
20%
Decompensated Liver Cirrhosis
20%
Esophagus Hemorrhage
20%
Pharmacology, Toxicology and Pharmaceutical Science
Beta Adrenergic Receptor Blocking Agent
100%
Liver Cirrhosis
100%
Portal Hypertension
100%
Varicosis
60%
Bleeding
40%
Ascites
40%
Pathophysiology
20%
Disease Course
20%
Disease
20%
Adverse Event
20%
Carvedilol
20%
Esophagus Varices
20%
Decompensated Liver Cirrhosis
20%
Brain Disease
20%
Esophagus Hemorrhage
20%